Learn how a DaTscan can help neurologists understand the cause of a patient’s tremors. Mark Hibberd, global head of medical services and chief medical officer of pharmaceutical diagnostics with GE Healthcare, explains.

Categories: Podcasts
Posted on January 5, 2021

December 24, 2020 — Among patients with Parkinson disease (PD), a positive history of essential tremor (ET) was found to be associated with slower progression of motor and nonmotor symptoms, with no impact observed on survival, according to study findings published in Scientific Reports.

Categories: In the News

CAMBRIDGE, Mass., December 17, 2020 – Cadent Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced today that it has reached a definitive agreement with Novartis, under which Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics. […]

Categories: In the News

I donated, for my first time, due to being an essential tremor (ET) patient myself and I see it as an opportunity to help others with ET by helping your organization in raising awareness. I have had ET since I was a child and now being 59 years old, I have seen how it affects […]

IETF: Past, Present and Future; Together We Can Make Life Better for People with ET; An Interview with Scholarship Recipient Madison Young.

Categories: Tremor Gram

By Richard Riehl,Freelance Writer Today I agreed to donate my brain to medical science. (I’ll pause here to allow regular readers of my published opinion pieces to stop laughing.) Twenty-two years ago, after an afternoon of heavy yard work, I reached for a cold beer and sat down to rest. As I brought the bottle […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for major depressive disorder (MDD), postpartum depression (PPD) and other psychiatric disorders and SAGE-324 for essential tremor and other neurological disorders.

Madison Young talks about her initial essential tremor diagnosis and how she has learned to explain her condition to others. She expresses her gratitude to those who support the IETF’s scholarship program. “I love having the support of the community behind me,” she said.

Categories: Podcasts

BURLINGAME, Calif.–(BUSINESS WIRE)–Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today reported data demonstrating the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting […]